RESULTS	Initial clinical responses were generally maintained through Week 244 ( PASI 75 : 63.4 % and 72.0 % ; PASI 90 : 39.7 % and 49.0 % ; PASI 100 : 21.6 % and 26.4 % ) for patients receiving 45 mg and 90 mg , respectively .\